PreMD Inc. Stock

Stocks

PREMF

CA74047Y1051

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for PreMD Inc. -.--% -

Valuation: PreMD Inc.

Market Cap 461K 403K 372K 343K 646K 44.38M 660K 4.44M 1.75M 21.74M 1.73M 1.69M 74.82M P/E 2006
-5.86x
P/E 2007 -5.08x
Enterprise Value 4.9M 4.28M 3.95M 3.64M 6.86M 472M 7.01M 47.21M 18.57M 231M 18.39M 17.99M 795M EV / Sales 2006
11,468,067x
EV / Sales 2007 399,046,792x
Free-Float
70.7%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 65 1992-11-08
Director TitleAgeSince
Director/Board Member 65 1992-11-08
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 38
-0.90%-0.15%+14.11%+78.64% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
-0.76%-1.44%-4.29%+36.97% 11.9B
-0.88%-0.62%+17.31%+88.26% 11.85B
+0.19%+2.87%+34.92%+137.61% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.75%-0.91%+17.45%+36.14% 6.91B
-.--%+0.14% - - 6.79B
-2.25%-2.08%+0.45%+210.44% 6.55B
Average -0.22%-0.55%+24.84%+86.58% 14.41B
Weighted average by Cap. -0.45%-0.68%+29.39%+87.71%

Financials

2006 2007
Net sales 3.34 2.91 2.69 2.48 4.67 321.2 4.78 32.15 12.64 157.31 12.53 12.25 541.54 0.09 0.08 0.08 0.07 0.13 9.1 0.14 0.91 0.36 4.46 0.35 0.35 15.35
Net income -5.95M -5.2M -4.8M -4.42M -8.33M -573M -8.52M -57.34M -22.55M -281M -22.34M -21.85M -966M -6.32M -5.52M -5.09M -4.69M -8.85M -608M -9.04M -60.88M -23.94M -298M -23.72M -23.2M -1.03B
Net Debt 3.07M 2.69M 2.48M 2.29M 4.31M 296M 4.4M 29.64M 11.66M 145M 11.55M 11.29M 499M 4.44M 3.88M 3.58M 3.3M 6.22M 427M 6.35M 42.77M 16.82M 209M 16.66M 16.3M 720M
Logo PreMD Inc.
PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company’s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company’s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.
Employees
-
  1. Stock Market
  2. Stocks
  3. PREMF Stock